Numeric Investors’s United Therapeutics UTHR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
$3.45M Buy
+23,300
New +$2.96M 0.03% 502
2017
Q2
Sell
-13,890
Closed -$1.88M 1168
2017
Q1
$1.88M Sell
13,890
-257,046
-95% -$38.9M 0.02% 497
2016
Q4
$38.9M Sell
270,936
-130,174
-32% -$16.6M 0.36% 63
2016
Q3
$47.4M Sell
401,110
-144,475
-26% -$17.4M 0.45% 55
2016
Q2
$57.8M Sell
545,585
-73,385
-12% -$8.19M 0.52% 48
2016
Q1
$69M Buy
618,970
+206,300
+50% +$26.1M 0.73% 30
2015
Q4
$64.6M Buy
412,670
+290,080
+237% +$42.2M 0.69% 33
2015
Q3
$16.1M Buy
122,590
+103,400
+539% +$16.6M 0.19% 116
2015
Q2
$3.34M Sell
19,190
-33,900
-64% -$6.1M 0.04% 317
2015
Q1
$9.15M Sell
53,090
-97,700
-65% -$14.9M 0.11% 185
2014
Q4
$19.5M Buy
150,790
+146,700
+3,587% +$18.9M 0.25% 97
2014
Q3
$526K Sell
4,090
-426,834
-99% -$44M 0.01% 581
2014
Q2
$38.1M Buy
430,924
+53,420
+14% +$5.14M 0.57% 42
2014
Q1
$35.5M Sell
377,504
-45,960
-11% -$4.7M 0.6% 37
2013
Q4
$47.9M Buy
423,464
+5,164
+1% +$466K 0.8% 30
2013
Q3
$33M Buy
418,300
+134,300
+47% +$9.82M 0.61% 37
2013
Q2
$18.7M Buy
+284,000
New +$18.3M 0.37% 62

Other funds holding UTHR

Numeric Investors's UTHR Position: Q4 2017 in Review

Numeric Investors opened a new position in United Therapeutics (UTHR) in Q4 2017: 23,300 shares worth $3.45M. The stake represents 0.03% of the portfolio and ranks #502 among its holdings. This is a return to the name: Numeric Investors previously reported a position in UTHR as recently as Q1 2017.

Numeric Investors first reported a position in UTHR in Q2 2013 and has held it in 17 quarters since. The position peaked at $69M in Q1 2016. 400 funds tracked by Wall St. Rank hold UTHR as of Q4 2017.

  • Numeric Investors held 23,300 shares of United Therapeutics worth $3.45M as of Q4 2017.
  • United Therapeutics was a new Numeric Investors position in Q4 2017.
  • United Therapeutics made up 0.03% of Numeric Investors's portfolio in Q4 2017, its #502 holding.
  • Numeric Investors first reported a position in United Therapeutics in Q2 2013 and has held it in 17 quarters since.
  • Numeric Investors's United Therapeutics position peaked at $69M in Q1 2016.
  • 400 funds tracked by Wall St. Rank held United Therapeutics as of Q4 2017.

Based on Numeric Investors's 13F filing for Q4 2017, filed 14 Feb 2018.